Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

framework for regulating healthcare artificial intelligence

US senators introduce legislation to strengthen payment for diagnostic imaging agents

The American College of Radiology, SNMMI and the Michael J. Fox Foundation, among others, voiced support for the FIND Act. 

Thumbnail

How age, gender and medical specialty affect a physician's risk of being sued

New data from the American Medical Association reveal that nearly one-third of physicians in the United States have been sued during their medical career. 

WHO warns against use of artificial sweeteners, highlighting CVD and diabetes risks

The World Health Organization has published a new guideline recommending against the use of artificial sweeteners such as aspartame and sucralose to lose weight or reduce the risk of noncommunicable diseases.

FDA grants fast track designation to Bayer’s new drug for preventing stroke in AFib patients

The new drug, asundexian, is currently the subject of two multicenter Phase III studies—the OCEANIC-AF trial and OCEANIC-STROKE trial—focused on its safety and efficacy.

Artificial intelligence in healthcare

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

framework for regulating healthcare artificial intelligence

A framework for regulating healthcare AI at the federal level has begun taking shape

America’s two major political parties agree on very little of late, but they have a mutual interest in working together toward overseeing AI.

'Bureaucratic and monetary hurdles' hinder international medical graduates' pursuit of radiology

Radiology trainee programs must overcome several barriers to offer J-1 and/or H-1B visas to trainees, with more difficulties associated with the latter.

brain money alzheimer dementia

Alzheimer’s drug could spur upward of $500M in new Medicare spending on imaging

Lecanemab requires a baseline PET scan and follow-up MRIs after infusions, spelling heavy demand for radiology services, experts wrote in JAMA.